A reasonable commercial basis, the size specific to the instrument for the purposes of obligations for systematic
2025/3000(DEA)
amending the regulatory technical standards laid down in Delegated Regulations (EU) 2017/583 and (EU) 2017/587 as regards transparency requirements for trading venues and investment firms in respect of bonds, structured finance products, emission allowances and equity instruments
2025/2773(DEA)
Equity Transaction Transparency
2023/2529(DEA)